Evidence map›Paper›PMID 39170205›Full record

ArticleHeliyon2024

Genetic and clinical study of

Mayu Ishiguro, Manabu Funayama, Taku Hatano, Hiroshi Nishida, Yuko Wada, Kazuyuki Noda, Masahiko Tomiyama, Hiroyo Yoshino, Yuanzhe Li, Stephanie Ong and 3 more

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mayu IshiguroDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Manabu FunayamaDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Taku HatanoDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Hiroshi NishidaDepartment of Neurology, Gifu Prefectural General Medical Center, Gifu, Japan.
Yuko WadaDepartment of Neurology, Rakuwa-kai Otowa Hospital, Kyoto, Japan.
Kazuyuki NodaDepartment of Neurology, Juntendo University Shizuoka Hospital, Shizuoka, Japan.
Masahiko TomiyamaDepartment of Neurology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Hiroyo YoshinoResearch Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Yuanzhe LiDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Stephanie OngDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Ettore CioffiDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Kenya NishiokaDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Nobutaka HattoriDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Biallelic variants in Objectives: To determine the prevalence and clinical features of patients with PD harboring Methods: We performed a molecular genetic analysis of PD patients with Results: Four patients with biallelic rare variants of Conclusions: To our knowledge, this is the first report of Japanese patients with

Indexed as

DJ-1Familial Parkinson's diseaseGenetics

Identifiers

PMID39170205
PMCPMC11336436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.